Predictive Oncology Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
POAI Nasdaq 2836 www.predictive-oncology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Predictive Oncology Inc.

Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives - Dec 3rd, 2024 12:00 pm
Predictive Oncology Third Quarter 2024 Earnings: Misses Expectations - Nov 15th, 2024 11:15 am
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update - Nov 13th, 2024 12:00 pm
Predictive Oncology Inc (POAI) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst ... - Oct 9th, 2024 10:23 pm
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Sep 5th, 2024 12:00 pm
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery - Aug 27th, 2024 12:00 pm
Predictive Oncology Inc. (NASDAQ:POAI) Is Expected To Breakeven In The Near Future - Aug 20th, 2024 10:16 am
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update - Aug 14th, 2024 11:00 am
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development - Aug 13th, 2024 11:00 am
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024 - Aug 7th, 2024 11:00 am
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds - Jul 26th, 2024 12:00 pm
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results - Jul 25th, 2024 11:00 am
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs) - Jun 11th, 2024 12:00 pm
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery - Jun 4th, 2024 12:42 pm
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024 - May 29th, 2024 11:00 am
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - May 28th, 2024 11:00 am
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update - May 15th, 2024 11:00 am
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024 - May 10th, 2024 11:00 am
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine - Apr 30th, 2024 8:05 pm
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - Apr 24th, 2024 8:05 pm